Food companies struggle to adapt to quickly changing

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
578
Food companies struggle to adapt to quickly changing consumer tastes

My thought>>>
I would think since most of the top 10 are global, that the rising tide of 3rd world affluence would be helping these companies.

https://www.fooddive.com/news/grocery--food-c...es/525206/

Dive Brief:
Consumers are shifting away from the packaged food staples of yesteryear in favor of fresher or cleaner-label options, The Wall Street Journal reported. Last year, unit volume of CPG products sold in center store fell by 1.7%, according to statistics from Nielsen cited by the Journal.

According to analysts at Credit Suisse, comparable sales for 10 large, publicly traded food companies have been flat or declined in three of the last four years.

CPG companies are facing increased competition from emerging brands through advertising and e-commerce delivery options that reach niche markets. They also are feeling squeezed through in-store meal kits and private label brands.

Dive Insight:
Without clear direction on what consumers are searching for, Big Food seems to be playing a game of blind man’s bluff. Smaller startup companies with explosive growth are easily reaching niche customers through social media. In-store meal kits and prepared foods are also filling the needs of some shoppers who are looking for unprocessed but easy-to-prepare meals.

A.T. Kearney’s 2016 study, "Is Big Food In Trouble," throws the stalled growth of legacy brands is thrown into sharp relief. Large CPG brands’ revenue grew at 1.8% compared to smaller companies, which saw revenue upticks ranging from 11% to 15%.

This decline is the culmination of years of changing consumer preferences, which clearly indicate shoppers are rejecting processed foods in favor of fresh, free-from and clean label options. Adding to the general wellness trend are explosive reports like this one, linking "ultra-processed" foods such as mass-produced bread, cakes and processed meats with an increased risk of cancer. This report and others go viral on social media and in consumer media, stoking the fears of health-conscious shoppers.

As CPGs are noticing the traction smaller and more health-conscious brands are getting, they are beginning to turn to more experimentation in their R&D departments, as well as leaning on each other through mega mergers and acquisitions.

In R&D, breakthroughs are coming that can bring old standard products back on trend. In 2016, Nestlé announced it was working on a "hollow sugar" molecule, enabling them to make candy that tastes as sweet with 40% less sugar. Their first candy bar with the innovation launched in the UK and Ireland in March.

Many recent big deals in the food and beverage space have also gone forward to help Big Food get back on trend. Last month, snack giant Mondelez bought cookie maker Tate's Bake Shop for $500 million, with the aim of getting into the fast-growing premium and authentic baked goods space. Cereal maker Kellogg spent $600 million to acquire RXBAR last year. The popular protein bars are not only big players in that space, but their wrappers featuring clear ingredient lists pretty well define the clean label trend.

In the hunt for the next best thing, large, legacy brands may want to get involved with upstarts in a way that leaves room for innovation and intrinsic growth. Almost every major CPG now have VC or incubator arms that are perpetually seeking the next profitable investment. Kraft Heinz, General Mills and Hain Celestial all work to mentor and support upstart brands — and learn from what they are doing. And while major brands have not necessarily acquired the companies they work with, they have learned a great deal about how to function as fearless startups.

There are also partnerships between major brands to develop new products to benefit both. Last year, AB InBev and Keurig announced plans to develop a beer K-cup. Kraft Heinz, Campbell Soup and Barilla dipped their toes into more experimental markets earlier this year, announcing a partnership with Ahold Delhaize's Peapod for its new meal kit recipes. These sound like good ideas, but it remains to be seen whether they will produce long-term profitability.

Flying in the face of all this is the question of choice. With so many trendy options forever vying for limited grocery shelf space, coupled with relentless information being shared about different food products, shoppers may experience decision fatigue. At the very least, ever-expanding choices and conflicting messages create a wall of noise that large brands may struggle to break through.

Similarly supermarkets, which have limited shelf space, may favor their private label brands. Consumers tend to like them too, mainly for lower price points and quality often at least comparable to national brands. According to the Private Label Manufacturers Association, private label brands now make up 17% of all grocery sales. A recent survey from retail services company Daymon found four out of five shoppers buy private brands on almost every shopping trip, and 85% trust private brands as much as national ones.

The market is continuing to churn out a dizzying variety of options. For meaningful changes in CPG sales, manufacturers have to meet the customer halfway, reformulating existing products and investing in wholesome, convenient options that focus more on freshness and nutrition, and less on shelf life.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 1

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Aterian Prepares for Upcoming Earnings Call This Quarter

Updated Category News Views 99

Aterian's Upcoming Financial Results Announcement Aterian, Inc. (Nasdaq: ATER), a prominent player in the consumer products sector, is gearing up to reveal its financial performance for the second quarter. Scheduled for Wednesday in the coming week, this announcement will take place after market closure, providing investors with valuable insights into the company’s...

Continue Reading
Analyzing RTX: Trends in Short Interest and Market Sentiment

Updated Category News Views 176

Understanding RTX's Recent Market Movements RTX Corp has seen a notable shift in its market dynamics recently. The company's short interest, defined as the number of shares sold short but not yet covered, has decreased by 7.63% since the last reporting period. Currently, there are approximately 16.18 million shares sold short, equating to 1.21% of all shares available for...

Continue Reading
Celebrate Christmas Spirit with Personalized PrayerSongs

Updated Category News Views 156

Celebrate the Joy of Christmas with PrayerSong Bring Love Into Your Home with a PrayerSong for Your Family and Friends When the holiday season arrives, the focus shifts beyond material gifts. Instead, it’s about nurturing connections filled with love, faith, and meaningful moments. This Christmas, PrayerSong provides families with a unique opportunity to honor loved...

Continue Reading
Understanding the Short Selling Landscape of Analog Devices

Updated Category News Views 153

Analyzing Short Interest for Analog Devices As investors navigate the ever-changing stock market, understanding short interest can provide valuable insights into market sentiment regarding Analog Devices (NYSE: ADI). Recently, it was reported that Analog Devices has seen a notable increase of 4.11% in its short percent of float. Currently, there are approximately 7.52...

Continue Reading
Future of Clinical Trials: Exploring Market Growth to USD 85.37 Billion

Updated Category News Views 71

Understanding Clinical Trials and Their Importance Clinical trials serve as a fundamental pillar in advancing medical knowledge and enhancing patient care. These trials encompass a detailed and thorough process involving participant recruitment, intervention administration, data collection, and result analysis. The outcomes produced from clinical trials play a crucial...

Continue Reading